TY - JOUR
T1 - Integrated approach to produce a recombinant, his-tagged human α-galactosidase a in mammalian cells
AU - Corchero, José Luis
AU - Mendoza, Rosa
AU - Lorenzo, Julia
AU - Rodríguez-Sureda, Victor
AU - Domínguez, Carmen
AU - Vázquez, Esther
AU - Ferrer-Miralles, Neus
AU - Villaverde, Antonio
PY - 2011/10/1
Y1 - 2011/10/1
N2 - Successful production of recombinant proteins (r-proteins) by transient gene expression (TGE) depends on several parameters (including producer cells, culture conditions, transfection procedure, or expression vector) that should be optimized when producing any recombinant product. In this work, TGE-based production of human α-galactosidase A (GLA) is described. Producer cells, expression vectors, and parameters influencing cell metabolism after transfection have been tested. The enzyme is secreted, has the right molecular weight, and is enzymatically active. Productivities of up to 30-40 mg/L have been achieved, with a simple, fast procedure. A 6 × His tag allows enzyme purification in a single step, rendering a highly pure product. We propose a TGE-based protocol able to produce up to several milligrams per liter of highly pure, active GLA in a time as short as a few days. By this, enough amounts of engineered versions of the enzyme can be easily produced to be tested in vitro or in preclinical trials. © 2011 American Institute of Chemical Engineers (AIChE).
AB - Successful production of recombinant proteins (r-proteins) by transient gene expression (TGE) depends on several parameters (including producer cells, culture conditions, transfection procedure, or expression vector) that should be optimized when producing any recombinant product. In this work, TGE-based production of human α-galactosidase A (GLA) is described. Producer cells, expression vectors, and parameters influencing cell metabolism after transfection have been tested. The enzyme is secreted, has the right molecular weight, and is enzymatically active. Productivities of up to 30-40 mg/L have been achieved, with a simple, fast procedure. A 6 × His tag allows enzyme purification in a single step, rendering a highly pure product. We propose a TGE-based protocol able to produce up to several milligrams per liter of highly pure, active GLA in a time as short as a few days. By this, enough amounts of engineered versions of the enzyme can be easily produced to be tested in vitro or in preclinical trials. © 2011 American Institute of Chemical Engineers (AIChE).
KW - Fabry's disease
KW - Human α-galactosidase A
KW - Mammalian cells
KW - Recombinant protein
KW - Transient gene expression
U2 - 10.1002/btpr.637
DO - 10.1002/btpr.637
M3 - Article
SN - 8756-7938
VL - 27
SP - 1206
EP - 1217
JO - Biotechnology Progress
JF - Biotechnology Progress
ER -